Loading clinical trials...
Loading clinical trials...
Random Open Exploratory Clinical Research of Sequential Gefitinib With Pemetrexed/Platinum Compare With Pemetrexed/Platinum Treatment for Advanced Non-small Cell Lung Cancer Exploratory Clinical Research
Conditions
Interventions
Sequential Gefitinib With Pemetrexed/Platinum
Pemetrexed/Platinum
Locations
1
China
Cancer hospital Fudan University
Shanghai, Shanghai Municipality, China
Start Date
December 1, 2009
Primary Completion Date
February 1, 2014
Last Updated
February 23, 2016
NCT07486219
NCT06305754
NCT05098132
NCT06731413
NCT04585750
NCT05987644
Lead Sponsor
Fudan University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions